Journal of Clinical Pharmacy and Therapeutics (1998) 23, 477-479 AUTHOR INDEX Ab Rahman, A.F. & Budiarti, L.E. Handling of drug-related Cohen, I., Rogers, P., Burke, V. & Beilin, L.J. Predictors of med- inquiries by hospital nurses, 127 ication use, compliance and symptoms of hypotension in a Aguado, J.M. see Romano, S community-based sample of elderly men and women, 423 Akhondzadeh, S. see Noorbala, A.A. Colen de Melo, P. see Dumortier, G. Akhondzadeh, S. The glutamate hypothesis of schizophrenia, Cordina, M., McElnay, J.C. & Hughes, C.M. Societal perceptions 243 of community pharmaceutical services in Malta, 115 Almeida, A.M., Falcaéo, A.C., Sales, F., Leitao, F., Santos, J., Costa, Cornil, P. see Schrijvers, D. I.M. & Caramona, M.M. Kinetic profile of carbamazepine in Cornwell, E.E. see Oparaoji, E.C. an adult Portuguese outpatient population, 315 Costa, I.M. see Almeida, A.M. Alpar, R. see Nasirideen, S. Critchley, J.A.J.H. see Chang, S. Amanlou, M. see Andalibi, P. Critchley, J.A.J.H. see Wu, S.Y.B. Andalibi, P., Farsam, H., Amanlou, M. & Gharouni, M. De- Critchley, J.A.J.H. see Yuen, Y.H termination of dosage requirements of warfarin in Iranian patients using HPLC technique, 199 Davies, J.G. see Phillips, G.J. Ang, S.Y., Peterson, G.M., Friesen, W.T. & Vial, J.H. Review of De Jong, R. see Natsch, S. antithrombotic drug usage in atrial fibrillation, 97 De Oliveira, I.R. see Macedo, J.M.S. Anton, J. see Romano, S. De Oliveira, IR. The treatment of unipolar major depression: Ara, J.R. see Pina, M.A. pharmacotherapy, cognitive behaviour therapy or both?, 473 Ashcroft, D.M., Li Wan Po, A., Williams, H.C. & Griffiths, C.E.M. De Smet, M.C. see Schrijvers, D Quality of life measures in psoriasis: a critical appraisal of Degrassat, K. see Dumortier, G. their quality, 391 Demoré, B., Benoit, E., Maincent, P., Hoffman, M. & Bessiére, J. Avery, A.J., Heron, T., Lloyd, D., Harris, C.M. & Roberts, D. Determination of heparin in aqueous solution, 381 Investigating relationships between a range of potential in- Doyle, J.C., Mottram, D.R. & Stubbs, H. Prescribing of ACI dicators of general practice prescribing: an observational inhibitors for cardiovascular disorders in general practice, study, 441 3a3n Dumortier, G., Lochu, A., Zerrouk, A., Van Nieuwenhuyse, V., Baines, D. & Whynes, D. The use of the ASTRO-PU and the Colen de Melo, P, Roche Rabreau, D. & Degrassat, K. Whole ASTRO(97)-PU in the setting of prescribing budgets in English saliva and plasma levels of clozapine and desmethyl- general practice, 229 clozapine, 35 Bashiri, M. see Oparaoji, E.C. Dunne, P.F. see Peterson, G.M. Beilin, L.J. see Cohen, I. Benoit, E. see Demoreé, B. Eagles, C.J & Martin, U. Non-pharmacological modification of Bessiere, J. see Demore, B. cardiac risk factors: part 3. Smoking cessation and alcohol Bhandari, S., Brownjohn, A. & Turney, J. Effective utilization of consumption, 1 erythropoietin with intravenous iron therapy, 73 Elemihe, U. see Oparaoji, E.C Bombardelli, E. see Nuttall, S.L. Elkis, H. see Macedo, | M.S. Brownjohn, A. see Bhandari, S. Bruyneel, P. see Schrijvers, D. Falcao, A.C. see Almeida, A.M. Budiarti, L.E. see Ab Rahman, A.F. Farsam, H. see Andalibi, P. Burgaz, S. see Torun, M. Friesen, W.T. see Ang, S.Y. Burke, V. see Cohen, I. Gabriel, V. see Harbarth, S. Caramona, M.M. see Almeida, A.M. Galloway, J].G. see Peterson, G.M. Castiella, J. see Pina, M.A. Garbino, J. see Harbarth, S. Chan, E.W. see How, T.H. Gharouni, M. see Andalibi, P. Chan, G.M.C. see Chang, S. Gholami, K., Tavakoli, N., Maleki, M. & Shafiee, A. Comparison Chan, J.C.N. see Chang, S. of the efficacy and safety of fenofibrate and lovastatin in Chan, J.C.N. see Wu, S.Y.B. patients with primary type Ia or I[b hyperlipidaemia, 213 Chan, J.C.N. see Yuen, Y.H. Gonzalez, P. see Romano, S. Chan, S.Y. see How, T.H. Greenaway, T.M. see Yap, W.S. Chan, W.H. see Chang, S. Griffiths, C.E.M. see Ashcroft, D.M. Chang, S. see Wu, S.Y.B. Chang, S. see Yuen, Y.H. Harbarth, S., Pittet, D., Gabriel, V., Garbino, J. & Lew, D. Cefepime Chang, S., Chan, W.H., Kong, Y., Chan, G.M.C., Raymond, K., — assessment of its need at a tertiary care center, 1] Lee, A., Lee, S.C., Critchley, J.A.J.H. & Chan, J.C.N. Use of Harris, C.M. see AV ery, A.J. indapamide in hospital and community clinics and its effect Hekster, Y.A. see Natsch, S. on plasma potassium in Chinese patients, 295 Henry, R.Y. & Kendall, M.J. Does cholesterol lowering prevent Cho, T. see Oparaoji, E.C. stroke?, 337 Chong, C.K.L. see Yuen, Y.H. Hermenegildo, M. see Sanchez-Alcaraz, A. ‘lark, W. see Misson, J. Heron, T. see Avery, A.J. Cobeta, J.C. see Pina Latorre, M.A. Hincal, A.A. see Nasirideen, S. © 1998 Blackwell Science Ltd 478 Author Index Ho, P.C. see How, T.H. Martin, U. see Eagles, C.]. Martin, U. see Kendall, M. Ho, P.C. see Sam, W,]. Hoffman, M. see Demoré, B. Mcdonald, C. & Muzumdar, P.P. Prevention of precipitation of Horiuchi, M. see Sugihara, H. phenytoin in an infusion fluid by hydroxypropyl f-cyclo- Hosono, K. see Iguchi, S. dextrin, 235 Hosseini, S.H. see Noorbala, A.A. McElnay, J.C. see Cordina, M. Hotta, M. see Sugihara, H. Mezghebe, H.M. see Oparaoji, E.C. How, T.H., Loo, W.Y., Yow, K.L., Lim, L.Y., Chan, E.W., Ho, P.C Mezghebe, H.M. see Oparaoji, E.C. & Chan, S.Y. Stability of cefazolin sodium eye drops, 41 Miller, K.A. see Peterson, G.M. Hughes, C.M. see Cordina, M. Misawa, S. see Tanaka, E. Misson, J., Clark, W. & Kendall, M.J. Clopidogrel: secondary Iguchi, S., Ohnishi, M., Nishiyama, T., Hosono, K. & Umezawa, prevention of vascular ischaemic events, 91 C. Community pharmacy practice in Japan — results of a Mitsuyama, Y. see Kodama, H. survey, 223 Mohammadi, M.R. see Noorbala, A.A. Morazzoni, P. see Nuttall, S.L. Kamo, T. see Sugihara, H. Mottram, D.R. see Doyle, J.C. Kanemaru, R. see Kodama, H. Murata, M. see Watanabe, T. Muzumdar, P.P. see Mcdonald, C. Kas, H.S. see Nasirideen, S. Keller, F. see Zellner, D. Kendall, M., Nuttall, S.L. & Martin, U. Antioxidant therapy — a Narita, N. see Sugihara, H. new therapeutic option for reducing mortality from coronary Nasirideen, S., Kas, H.S., Oner, F.,, Alpar, R. & Hincal, A.A. artery disease, 323 Naproxen incorporated lipid emulsions. I. Formulation and Kendall, M.J. & Toescu, V. The HOT Study, 137 stability studies, 57 Kendall, M.]. see Henry, R.Y. Natsch, S., Van Leeuwen, S.J., De Jong, R. & Hekster, Y.A. Use Kendall, M.]. see Misson, J. of albumin in intensive care unit patients — is continuous Kendall, M.J. see Nuttall, S.L. quality assessment necessary?, 179 Kilwein, J.H. Reflections on pain, 327 Navarro, N. see Pina Latorre, M.A. Kingswood, C. see Phillips, G.J. Negishi, Y. see Sugihara, H. Klinker, H., Langmann, P., Zilly, M. & Richter, E. Drug monitoring Nishiyama, T. see Iguchi, S. during the treatment of AIDS-associated Pneumocystis carinii Noorbala, A.A., Hosseini, S.H., Mohammadi, M.R. & Ak- pneumonia with trimethoprim-sulfamethoxazole, 149 hondzadeh, S. Combination of clomipramine and_nor- Kodama, H., Kodama, Y., Shinozawa, S., Kanemaru, R., Todaka, triptyline in the treatment of obsessive-compulsive disorder: K. & Mitsuyama, Y. Serum protein binding kinetics of a double-blind, placebo-controlled trial, 155 phenytoin in monotherapy patients, 361 Nugent, J., Li Wan Po, A. & Scott, E.M. Design and delivery of Kodama, Y. see Kodama, H. non-parenteral vaccines, 257 Kong, Y. see Chang, S. Nuttall, S.L. see Kendall, M. Nuttall, S.L., Kendall, M.J., Bombardelli, E. & Morazzoni, P. An Laguarda, M. see Sanchez-Alcaraz, A. evaluation of the antioxidant activity of a standardised grape Lanao, J.M. see Romano, S. seed extract, Leucoselect®, 385 Langmann, P. see Klinker, H. Lee, A. see Chang, S. Ohnishi, M. see Iguchi, S. Lee, S.C. see Chang, S. Ohta, M. see Watanabe, T. Lee, Sx. see W u, S.Y.B. Olliff, C.J. see Phillips, G.J. Lee, S.C. see Yuen, YH. Oner, F. see Nasirideen, S. Leitao, F. see Almeida, A.M. Oparagji, E.C., Siram, S., Elemihe, U., Mezghebe, H.M., Cho, T., Lew, D. see Harbarth, S. Bashiri, M., Piedrahita, K. & Pipalla, R.S. Aminoglycoside Li Wan Po, A. see Ashcroft, D.M. pharmacokinetics in African-Americans with normal renal Li Wan Po, A. see Nugent, J. Li Wan Po, A. see Pacey, S. function, 191 Li Wan Po, A. see Pacey, S. Oparaoji, E.C., Siram, S., Shoheiber, O., Cornwell, E-E. & Mez- ghebe, H.M. Appropriateness of a 4mg/kg gentamicin or Li Wan Po, A. The British National Health Service (NHS) celebrates its 50th anniversary: equity in a competitive tobramycin loading dose in post-operative septic shock world, 241 patients, 185 Lim, L.Y. see How, T.H. Osbakken, M. see Rosenstock, J. Lin, C.S. see Rosenstock, J. Lloyd, D. see Avery, A.J. Pacey, S. & Li Wan Po, A. A review of methods of drug cost Lochu, A. see Dumortier, G. management in hospitals, 171 Loo, W.Y. see How, T.H. Pacey, S., Warner, J. & Li Wan Po, A. A multidisciplinary Lopez, E. see Sanchez-Alcaraz, A. approach to hospital-based drug cost containment, 203 Lung, B.C.H. see Wu, S.Y.B. Peterson, G.M. see Ang, S.Y. Peterson, G.M. see Yap, W.S. Macedo, C.R.B. see Macedo, J.M.S. Peterson, G.M., Miller, K.A., Galloway, J.G. & Dunne, P.F. Com- Macedo, J.M.S., Macedo, C.R.B., Elkis, H. & De Oliveira, LR. patibility and stability of fentanyl admixtures in poly- Meta-analysis about efficacy of anti-resorptive drugs in post- propylene syringes, 67 menopausal osteoporosis, 345 Phillips, G.J., Davies, J.G., Olliff, C.J., Kingswood, C. & Street, MacNeil, D. see Rosenstock, J. M. Use of in vitro models of haemofiltration and haemo- Maincent, P. see Demoré, B. diafiltration to estimate dosage regimens for critically ill Maleki, M. see Gholami, K. patients prescribed cefpirome, 353 © 1998 Blackwell Science Ltd, Journal of Clinical Pharmacy and Therapeutics, 23, 477-479 Author Index 479 Piedrahita, K. see Oparaoji, E.C.Pina Latorre, M.A., Cobeta, J.C., the pharmacokinetics of cefpirome sulphate in the elderly, Rodilla, F., Navarro, N. & Zabala, S. Influence of calcium 375 antagonist drugs in myasthenia gravis in the elderly, 399 Pina, M.A., Ara, J.R., Remirez, A. & Castiella, J. Verapamil and Tai-Apin, C. see Schrijvers, D. acute dystonia, 79 Takatsu, R. see Sugihara, H. Pipalla, R.S. see Oparaoji, E.C. Tanaka, E. & Misawa, S. Pharmacokinetic interactions between Pittet, D. see Harbarth, S. acute alcohol ingestion and single doses of benzodiazepines, Poveda, ].L. see Sanchez-Alcaraz, A. and tricyclic and tetracyclic antidepressents — an update, 331 fanaka, E. Clinical importance of non-genetic and genetic cyto- Querol, J.M. see Sanchez-Alcaraz, A. chrome P450 function tests in liver disease, 161 Quintana, M.B. see Sanchez-Alcaraz, / Tanaka, E. Clinically important pharmacokinetic drug-drug inter- Quintana, M.B. see Sanchez-Alcaraz, / actions: role of cytochrome P450 enzymes, 403 Quintana, M.B. see Sanchez-Alcaraz, / Tanaka, E. In vivo age-related changes in hepatic drug-oxidizing capacity in humans, 247 Randall, C.T.C. see Yap, W.S. Tavakoli, N. see Gholami, K. Raymond, K. see Chang, S. Tejada, P. see Romano, S. Reddy, P. A review of the newer aromatase inhibitors in the Todaka, K. see Kodama, H. management of metastatic breast cancer, 81 Toescu, V. see Kendall, M.J. Remrez, A. see Pina, M.A. Torun, M., Yardim, S., Simsek, B. & Burgaz, S. Serum uric acid Richter, E. see Klinker, H. levels in cardiovascular diseases, 25 Roberts, D. see Avery, A.J. Iruter, I. An investigation into antidiabetic medication pre- Roche Rabreau, D. see Dumortier, G. scribing in South Africa, 417 Rocher, A. see Sanchez-Alcaraz, A. Turney, J. see Bhandari, S. Rodilla, F. see Pina Latorre, M.A. Rodriguez, I. see Sanchez-Alcaraz, A. Umezawa, C. see Iguchi, S. Rogers, P. see Cohen, I. Romano, S., Gonzalez, P., Tejada, P., Anton, J., Aguado, J.M. & Van Leeuwen, S.J]. see Natsch, S. Lanao, J.M. Influence of diagnostic and treatment factors in Van Nieuwenhuyse, V. see Dumortier, G. the population pharmacokinetics of gentamicin, 141 Vargas, A. see Sanchez-Alcaraz, A. Rosenstock, J., Rossi, L., Lin, C.S., MacNeil, D. & Osbakken, M. Vermorken, J.B. see Schrijvers, D. The effects of irbesartan added to hydrochlorothiazide for Vial, J.H. see Ang, S.Y. the treatment of hypertension in patients non-responsive to Vial, J.H. see Yap, W.S. hydrochlorothiazide alone, 433 Rossi, L. see Rosenstock, J. Warner, J. see Pacey, S. Watanabe, T., Ohta, M., Murata, M. & Yamamoto, T. Decrease in Sales, F. see Almeida, A.M. emergency room or urgent care visits due to management of Sam, W.]. & Ho, P.C. Stability of captopril in invert sugar solution, bronchial asthma inpatients and outpatients with phar- 45] maceutical services, 303 Sanchez-Alcaraz, A., Quintana, M.B. & Laguarda, M. Placental Whynes, D. see Baines, D. transfer and neonatal effects of propofol in caesarean section, Williams, H.C. see Ashcroft, D.M. 19 Wu, S.Y.B., Lung, B.C.H., Chang, S., Lee, $.C., Critchley, J.A.J.H. Sanchez-Alcaraz, A., Quintana, M.B., Lopez, E. & Rodriguez, I. & Chan, J.C.N. Evaluation of drug usage and expenditure in Valproic acid clearance in children with epilepsy, 31 a hospital diabetes clinic, 49 Sanchez-Alcaraz, A., Vargas, A., Quintana, M.B., Rocher, A., Querol, J.M., Poveda, J.L. & Hermenegildo, M. Therapeutic Yamamoto, T. see Watanabe, T. drug monitoring of tobramycin: once-daily versus twice-daily Yap, W.S., Peterson, G.M., Vial, J.H., Randall, C.T.C. & Green- dosage schedules, 367 away, T.M. Review of management of type 2 diabetes mellitus, Santos, J. see Almeida, A.M. 457 Schrijvers, D., Tai-Apin, C., De Smet, M.C., Cornil, P., Vermorken, Yardim, S. see Torun, M. |.B. & Bruyneel, P. Determination of compatibility and sta- Yonenami, K. see Sugihara, H. bility of drugs used in palliative care, 311 Yow, K.L. see How, T.H. Scott, E.M. see Nugent, I. Yuen, Y.H., Chang, S., Chong, C.K.L., Lee, S.C., Critchley, J.A.J.H. Shafiee, A. see Gholami, K. & Chan, J.C.N. Drug utilization in a hospital general medical Shibhara, K. see Sugihara, H. outpatient clinic with particular reference to antihypertensive Shinozawa, S. see Kodama, H. and antidiabetic drugs, 287 Shoheiber, O. see Oparaoji, E.C. Simsek, B. see Torun, M. Zabala, S. see Pina Latorre, M.A. Siram, S. see Oparaoji, E.C. Zellner, D., Zellner, G.E. & Keller, F. Dependence of vancomycin Siram, S. see Oparaoji, E.C. clearance on renal function via regression and bootstrap Street, M. see Phillips, G_J. methods, 107 Stubbs, H. see Doyle, J.C. Zellner, G.E. see Zellner, D. Sugihara, H., Narita, N., Takatsu, R., Horiuchi, M., Yonenami, Zerrouk, A. see Dumortier, G. K., Hotta, M., Shibhara, K., Kamo, T. & Negishi, Y. Study of Zilly, M. see Klinker, H. © 1998 Blackwell Science Ltd, Journal of Clinical Pharmacy and Therapeutics, 23, 477-479